The latest scientific articles, laboratory findings, and quality assurance documentation for Nojin biological products.
A scientific step toward bridging academic research and advanced industrial production technology in the country.
Compliance with Good Manufacturing Practice (GMP) legal requirements in warehousing and distribution ensures the safety and efficacy of biological products.
Nojin Biopharma's pharmaceutical portfolio is expanding with new clinical treatment options to maximize coverage of the country's therapeutic needs.
Injectable biological formulations are highly sensitive to environmental changes and shear forces. The use of nano-systems can improve the physicochemical stability of active proteins during storage.
Achieving technological independence in the human blood plasma fractionation chain is a strategic goal for the country in pharmaceutical biotechnology. In this scientific monograph, we review the achievements of Nojin's R&D in localizing advanced membrane separation methods.
There is currently no active research in this category. New scientific findings will be uploaded in this section after final approval by the editorial board.
Nojin Biopharma, relying on GMP standards, is a pioneer in manufacturing human plasma-derived biological products to promote the country's biosafety.